You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

STAVZOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Stavzor patents expire, and what generic alternatives are available?

Stavzor is a drug marketed by Bionpharma and is included in one NDA.

The generic ingredient in STAVZOR is valproic acid. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Stavzor

A generic version of STAVZOR was approved as valproic acid by CATALENT on October 29th, 1991.

  Try a Trial

Drug patent expirations by year for STAVZOR
Recent Clinical Trials for STAVZOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Barbara Ann Karmanos Cancer InstitutePhase 1
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhase 2
PfizerPhase 2

See all STAVZOR clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for STAVZOR

US Patents and Regulatory Information for STAVZOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-001 Jul 29, 2008 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bionpharma STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-002 Jul 29, 2008 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bionpharma STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-003 Jul 29, 2008 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.